Pathogenesis and Clinical Practice in Gastroenterology

  • I. Ferkolj
  • A. Gangl
  • P. R. Galle
  • B. Vucelic
Conference proceedings

Part of the Falk Symposium book series (FASS, volume 160)

Table of contents

  1. Front Matter
    Pages i-xv
  2. Dysphagia and reflux

  3. Helicobacter pylori, NSAID, gastric cancer

    1. Front Matter
      Pages 31-31
    2. K. Mönkemüller, H. Neumann, L. C. Fry, P. Malfertheiner
      Pages 33-40
  4. Inflammatory bowel disease section

  5. Lower gastrointestinal tract (coeliac disease, infection and malignancy)

    1. Front Matter
      Pages 95-95
    2. S. Kolaček
      Pages 97-109
    3. J. Tomažič
      Pages 110-112
    4. B. Štabuc, S. Plut
      Pages 113-117
  6. Clinical challenges in liver diseases

    1. Front Matter
      Pages 125-125
    2. C. Flechtenmacher, T. Longerich, P. Schirmacher
      Pages 127-136
    3. S. P. Hussain, X. W. Wang, C. C. Harris
      Pages 137-146
  7. Viral hepatitis

    1. Front Matter
      Pages 147-147
    2. B. Kronenberger, S. Zeuzem
      Pages 161-168
  8. Metabolic and autoimmune liver injury

    1. Front Matter
      Pages 169-169
    2. S. Kanzler
      Pages 186-190
    3. A. Lleo, C. Selmi, P. Invernizzi, M. Podda, M. E. Gershwin
      Pages 191-207
    4. H. Tilg
      Pages 208-217
  9. Complications of cirrhosis

    1. Front Matter
      Pages 219-219
    2. A. L. Gerbes
      Pages 221-232
    3. T. Sauerbruch, J. Trebicka
      Pages 233-238
    4. G. Otto, M. Hoppe-Lotichius, M. Heise
      Pages 266-274
  10. Back Matter
    Pages 275-280

About these proceedings


The translation of new molecular understanding of disease into clinical practice in gastroenterology is a special challenge. The Falk Symposium No. 160, entitled ‘Pathogenesis and Clinical Practice in Gastroenterology’, held 15-16 June 2007 in Portorož, Slovenia, provided a stimulating framework to bridge discussions from bench to bedside. The proceedings of the symposium are contained in this book, and the unifying theme is the growing understanding of inflammation as a driving force in chronic disease leading to disability and malignancy.

Aspects of early detection - endoscopically or via molecular markers - are covered as well as in-depth discussions of the validation of new findings in clinical practice.

Whilst on a molecular basis gastroenterologists and hepatologists try to shed light on the same intracellular pathways, clinical implications such as surveillance of cancer in IBD or chronic hepatitis with cirrhosis have to be tailored to specific needs.

New therapeutic agents - approved or on the horizon of early clinical studies - will dramatically change the options of patients with chronic disease such as Crohn’s disease, viral hepatitis or hepatocellular carcinoma.


cancer diseases endoscopy gastric cancer gastroenterology gastrointestinal tract helicobacter pylori hepatitis immunology infection inflammation liver liver disease physiology viral hepatitis

Editors and affiliations

  • I. Ferkolj
    • 1
  • A. Gangl
    • 2
  • P. R. Galle
    • 3
  • B. Vucelic
    • 4
  1. 1.Department of GastroenterologyMedical Centre LjubljanaSlovenia
  2. 2.University of ViennaViennaAustria
  3. 3.University of MainzMainzGermany
  4. 4.University Hospital RebroZagrebCroatia

Bibliographic information